118 related articles for article (PubMed ID: 12383321)
21. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
Inki P; Hurskainen R; Palo P; Ekholm E; Grenman S; Kivelä A; Kujansuu E; Teperi J; Yliskoski M; Paavonen J
Ultrasound Obstet Gynecol; 2002 Oct; 20(4):381-5. PubMed ID: 12383322
[TBL] [Abstract][Full Text] [Related]
22. Gene expression associated with unfavorable vaginal bleeding in women using the etonogestrel subdermal contraceptive implant: a prospective study.
Torelli FR; Rodrigues-Peres RM; Monteiro I; Lopes-Cendes I; Bahamondes L; Juliato CRT
Sci Rep; 2024 May; 14(1):11062. PubMed ID: 38745005
[TBL] [Abstract][Full Text] [Related]
23. Implant contraception.
Meckstroth KR; Darney PD
Semin Reprod Med; 2001 Dec; 19(4):339-54. PubMed ID: 11727176
[TBL] [Abstract][Full Text] [Related]
24. Implanon. The new alternative.
Cherry S
Aust Fam Physician; 2002 Oct; 31(10):897-900. PubMed ID: 12404826
[TBL] [Abstract][Full Text] [Related]
25. [Transvaginal sonography of the postmenopausal endometrium].
Curcić A; Segedi D; Belopavlović Z; Petrović D
Med Pregl; 2000; 53(1-2):59-63. PubMed ID: 10953553
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
[TBL] [Abstract][Full Text] [Related]
27. Bleeding problems and progestogen-only contraception.
Porter C; Rees MC
J Fam Plann Reprod Health Care; 2002 Oct; 28(4):178-81. PubMed ID: 12419054
[No Abstract] [Full Text] [Related]
28. Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure.
Sit AS; Modugno F; Hill LM; Martin J; Weissfeld JL
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1459-65. PubMed ID: 15342446
[TBL] [Abstract][Full Text] [Related]
29. The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium.
Macpherson AM; Archer DF; Leslie S; Charnock-Jones DS; Makkink WK; Smith SK
Hum Reprod; 1999 Dec; 14(12):3080-7. PubMed ID: 10601100
[TBL] [Abstract][Full Text] [Related]
30. Use of etonogestrel implant beyond approved duration: prolonged contraceptive effectiveness.
Ribeiro BC; Nogueira-Silva C; Afonso H; Silva PO; Reis ID
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):309-310. PubMed ID: 30203680
[TBL] [Abstract][Full Text] [Related]
31. Bleeding patterns of women using extended regimens of the contraceptive vaginal ring.
Barreiros FA; Guazzelli CA; de Araújo FF; Barbosa R
Contraception; 2007 Mar; 75(3):204-8. PubMed ID: 17303490
[TBL] [Abstract][Full Text] [Related]
32. Comments on Implanon review.
O'Brien PA
Br J Fam Plann; 2000 Apr; 26(2):117-8. PubMed ID: 10896466
[No Abstract] [Full Text] [Related]
33. The long-term effects of progesterone-only contraceptives on endometrium and ovary in rats.
Lortlar N; Kilic S; Peker T; Zulfikaroglu E; Omeroglu S; Erbas D; Celik HH; Kormaz A; Tatar I
Arch Gynecol Obstet; 2010 Jun; 281(6):1051-9. PubMed ID: 20084388
[TBL] [Abstract][Full Text] [Related]
34. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
[TBL] [Abstract][Full Text] [Related]
35. Association of body mass index with removal of etonogestrel subdermal implant.
Casey PM; Long ME; Marnach ML; Fleming-Harvey J; Drozdowicz LB; Weaver AL
Contraception; 2013 Mar; 87(3):370-4. PubMed ID: 22959901
[TBL] [Abstract][Full Text] [Related]
36. Effects of a single Silastic contraceptive implant containing nomegestrol acetate (Uniplant) on endometrial morphology and ovarian function for 1 year.
Barbosa IC; Maia H; Coutinho E; Lopes R; Lopes AC; Noronha C; Botto A
Contraception; 2006 Dec; 74(6):492-7. PubMed ID: 17157108
[TBL] [Abstract][Full Text] [Related]
37. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; Cedeño-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
[TBL] [Abstract][Full Text] [Related]
38. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
Wildemeersch D; Janssens D; Weyers S
Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
[TBL] [Abstract][Full Text] [Related]
39. Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population.
Di Carlo C; Guida M; De Rosa N; Sansone A; Gargano V; Cagnacci A; Nappi C
Gynecol Endocrinol; 2015 Jun; 31(6):491-4. PubMed ID: 26213863
[TBL] [Abstract][Full Text] [Related]
40. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
Hou MY; McNicholas C; Creinin MD
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
